老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ascendis Pharma A/S

223.21
-3.7900-1.67%
盘后：223.210.00000.00%19:30 EDT
成交量：59.22万
成交额：1.33亿
市值：147.74亿
市盈率：17.58
高：228.91
开：225.99
低：222.21
收：227.00
52周最高：282.15
52周最低：186.05
股本：6,618.99万
流通股本：6,553.95万
量比：0.69
换手率：0.90%
股息：- -
股息率：- -
每股收益(TTM):12.70
每股收益(LYR):-4.4176
净资产收益率：118.78%
总资产收益率：9.58%
市净率：9.18
市盈率(LYR):-50.53

数据加载中...

总览公司新闻资讯公告
2019/05/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/12

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/03/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/12

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/02/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/11

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/01/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多